View Older Stories View More Recent Stories

Aug 31, 2022 09:00AM Lumos Pharma to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
Aug 16, 2022 07:30AM Lumos Pharma, Inc. (LUMO) Announces $3M Share Buyback
Aug 16, 2022 07:30AM Lumos Pharma Announces Share Repurchase Program
Aug 16, 2022 07:30AM Lumos Pharma Announces Share Repurchase Program
Aug 15, 2022 04:53PM Form 13F-HR DEERFIELD MANAGEMENT For: Jun 30
Aug 15, 2022 04:30PM ADC Therapeutics Announces $175 million Senior Secured Term Loan from Owl Rock and Oaktree and Settlement of Existing Senior Secured Convertible Notes
Aug 15, 2022 07:35AM Miravo Healthcare™ Announces Second Quarter 2022 Results
Aug 12, 2022 07:00AM Vigil Neuroscience (VIGL) Announces $75 Million Private Placement of Common Stock, Warrants
Aug 12, 2022 07:00AM Vigil Neuroscience Announces $75 Million Private Placement Financing
Aug 12, 2022 07:00AM Vigil Neuroscience Announces $75 Million Private Placement Financing
Aug 9, 2022 04:07PM The Oncology Institute, Inc (TOI) Announces $110M Investment by Deerfield Management
Aug 9, 2022 04:06PM The Oncology Institute Reports Second Quarter 2022 Financial Results and Reaffirms Full Year 2022 Guidance
Aug 9, 2022 04:06PM The Oncology Institute Reports Second Quarter 2022 Financial Results and Reaffirms Full Year 2022 Guidance
Aug 9, 2022 04:05PM The Oncology Institute announces $110 million strategic investment by Deerfield Management to accelerate its expansion into new markets
Aug 9, 2022 04:05PM The Oncology Institute announces $110 million strategic investment by Deerfield Management to accelerate its expansion into new markets
Aug 9, 2022 04:01PM Lumos Pharma Reports Second Quarter 2022 Financial Results and Clinical Development Updates
Aug 9, 2022 04:01PM Lumos Pharma Reports Second Quarter 2022 Financial Results and Clinical Development Updates
Aug 4, 2022 08:00AM Endologix Receives CE Mark Certification under EU-MDR for AFX®2 Endovascular AAA System
Aug 2, 2022 11:00AM Element Science Announces First Patient Save with Jewel Patch Wearable Cardioverter Defibrillator (P-WCD)
Aug 2, 2022 09:30AM NYC Healthcare Innovation Campus, Cure®, Fuels Economic Growth
Jul 28, 2022 07:00AM Vicinitas Therapeutics Launches With $65 Million in Series A Financing to Advance Precision Medicines to Stabilize Key Proteins to Treat Disease
Jul 27, 2022 04:05PM Lumos Pharma to Report Second Quarter 2022 Financial Results and Host Conference Call on August 9, 2022
Jul 27, 2022 04:05PM Lumos Pharma to Report Second Quarter 2022 Financial Results and Host Conference Call on August 9, 2022
Jul 20, 2022 08:00AM Medical Microinstruments Secures $75M to Advance Robotic Microsurgery
Jul 19, 2022 02:18PM Conventus Flower Orthopedics Appoints Bradley Niemann as Chief Executive Officer
Jul 18, 2022 11:00AM Humanity Health Announces $6 Million Series A Funding Round
Jul 14, 2022 08:00AM Apertura Appoints Gene Therapy Executive Joseph La Barge as Chief Executive Officer
Jul 1, 2022 06:30AM Acutus Medical Completes First Closing of Transaction with Medtronic and Debt Refinancing to Fund Strategic Growth Priorities
Jun 23, 2022 08:30AM Endologix Reports 12 Month Data from DETOUR 2 Clinical Trial at 2022 Vascular Annual Meeting
Jun 22, 2022 11:05AM CobiCure launches to change the course of pediatric healthcare
Jun 21, 2022 04:14PM Form 4 Nuvalent, Inc. For: Jun 16 Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
Jun 2, 2022 04:04PM Form SC 13D/A CareMax, Inc. Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
Jun 2, 2022 09:36AM EPIC SCIENCES RAISES $43M IN FIRST CLOSE OF SERIES F FINANCING TO ADVANCE COMPREHENSIVE PROFILING FOR METASTATIC CANCER PATIENTS
Jun 1, 2022 10:28AM EPIC SCIENCES RAISES $42M IN FIRST CLOSE OF SERIES F FINANCING TO ADVANCE COMPREHENSIVE PROFILING FOR METASTATIC CANCER PATIENTS
May 25, 2022 10:00AM Adela Initiates Key Study for Cancer Early Detection Program
May 23, 2022 10:00AM Adela Announces Executive and Board of Directors Appointments and Formation of Scientific Advisory Board
May 23, 2022 06:02AM Axon Therapies Announces Positive Early Clinical Data from REBALANCE-HF Randomized Clinical Trial
May 18, 2022 09:02AM Biotech Acquisition (BIOT) and Blade Report Preclinical Data Highlighting Differentiating Characteristics of Cudetaxestat
May 18, 2022 09:01AM Blade Therapeutics Presents Preclinical Data Highlighting Differentiating Characteristics of Cudetaxestat at the American Thoracic Society 2022 International Conference
May 18, 2022 08:39AM Perceive Biotherapeutics Appoints Anne E. Fung MD, as Chief Medical Officer to Drive Transformational Clinical Programs
May 17, 2022 07:00AM Civetta Therapeutics Appoints Jesse Smith, Ph.D. as CSO and Susan Ashwell, Ph.D. as SVP of Chemistry
May 16, 2022 05:11PM Form 13F-HR DEERFIELD MANAGEMENT For: Mar 31
May 16, 2022 04:05PM Lumos Pharma to Participate in Upcoming Investor Conferences
May 16, 2022 04:05PM Lumos Pharma to Participate in Upcoming Investor Conferences
May 16, 2022 09:02AM Blade Therapeutics (BIOT) Reports Data from Phase 1 and Preclinical Studies of Cudetaxestat
May 16, 2022 09:01AM Blade Therapeutics Presents Data from Phase 1 and Preclinical Studies of Cudetaxestat at the American Thoracic Society 2022 International Conference
May 16, 2022 07:30AM Miravo Healthcare™ Announces First Quarter 2022 Results
May 11, 2022 05:43PM Form 4 Larimar Therapeutics, For: May 10 Filed by: DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
May 10, 2022 04:01PM Lumos Pharma Reports First Quarter 2022 Financial Results and Clinical Development Updates
May 10, 2022 04:01PM Lumos Pharma Reports First Quarter 2022 Financial Results and Clinical Development Updates
View More Recent Stories View Older Stories